期刊文献+

耐药基因与凋亡相关基因在肺癌中的表达及其意义 被引量:2

下载PDF
导出
出处 《中国肿瘤临床与康复》 2005年第1期28-29,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
  • 相关文献

参考文献3

二级参考文献16

  • 1刘叙仪,方红,方健,张晖.59例难治性肺癌化疗并异博定和(或)三苯氧胺疗效[J].中国肿瘤临床,1996,23(4):229-235. 被引量:15
  • 2[1]Pujol JL, Simony J, Gautier V, et al. Immunohistochemical study of P-glycoprotein distribution in lung cancer. Lung Cancer,1993,10(1-2)∶1-12.
  • 3[2]Raviv Y, Pollard HB, Bruggemann EP, et al. Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. J Biol Chem,1990,265(7)∶3975-3980.
  • 4[3]Ueda K, Cardarelli C, Gottesman MM, et al. Expression of a full-length cDNA for the human “MDR1” gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA,1987,84(9)∶3004-3008.
  • 5[4]van der Valk P, van Kalken CK, Ketelaars H, et al. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. Ann Oncol,1990,1(1)∶56-64.
  • 6[5]Goldstein LJ, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst,1989,18(2)∶116-124.
  • 7[6]Lum BL, Gosland MP, Kaubisch S, et al. Molecular targets in oncology: implications of the multidrug resistance gene. Pharmacotherapy,1993,13(2)∶88-109.
  • 8易成,胡颖川,侯梅,任莉,陈晓峰,张尚福,成娘,周清华.MDR_1基因产物在非小细胞肺癌中的表达研究[J].中国胸心血管外科临床杂志,1997,4(2):73-75. 被引量:4
  • 9高振强,高志萍,刘喜富,张志华,张涛,孙仁会.逆转病毒介导的突变型p53基因增加人肺癌细胞耐药性研究[J].中国科学(C辑),1997,27(2):168-172. 被引量:1
  • 10戴广海,石廷章,李春海.肺癌组织MDR1和GST-πmRNA水平测定及其临床意义[J].中国肿瘤临床,1999,26(3):165-168. 被引量:7

共引文献36

同被引文献18

  • 1王国安,刘海峰,房殿春,腾小春,陈刚,何俊堂.胃癌前组织和胃癌中hTERT、Bcl-2蛋白的表达及其相互关系[J].胃肠病学和肝病学杂志,2004,13(6):612-615. 被引量:2
  • 2王建奇,卢洪流,韩燕华,柯以铨,徐如祥.脑胶质瘤中端粒酶活性及P-gp糖蛋白表达的相关性[J].军事医学科学院院刊,2004,28(6):527-529. 被引量:1
  • 3段钊,曲群,赵玲,陈青娟,王桂贤,马玉琴,杜稳侠.P-gp和Topo-Ⅱ在子宫内膜癌组织中的表达及意义[J].中华肿瘤防治杂志,2006,13(24):1873-1875. 被引量:1
  • 4梁智勇,王文泽,高洁,武莎斐,曾瑄,刘彤华.胰腺导管腺癌中HER2/neu和拓扑异构酶Ⅱα基因的变化及相关性分析[J].中华病理学杂志,2007,36(2):102-106. 被引量:6
  • 5Kubota T, Egawa T, Otani Y, et al. Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages Ⅲ/Ⅳ gastric cancer without peritoneal dissemination. Anticancer Res, 2003,23 :583-587.
  • 6Samson DJ, Seidenfeld J, Ziegler K, et al. Chemotherapy sensitivity and resistance assays: a systematic review. J Clin Oncol, 2004,22 : 3618-3630.
  • 7Nakamura R, Saikawa Y, Kubata T, et al. Role of the MTr chemosensitivity test in prognosis of gastric cancer patients after postoperative adjuvant chemotherapy. Anticancer Res, 2006,26 : 1433-1440.
  • 8Miyasgita T, Reel JC. Bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a human leukemia cell line. Blood, 1993,81 : 151-157.
  • 9Valera ET,Machado HR,Scrideli CA,et al.Drug resistance in central nervous system tumors:from the traditional cell-resistance model to the genetically driven approaches on therapy[J].Curr Pharm Biotechnol,2007,8 (2):105-113.
  • 10Spiegl-Kreinecker S,Buchroithner J,Elbling L,et al.Expression and functional activity of the ABC-transporter proteins P-glycoprotein and mutidrug-resistance protein1in human brain cells and astrocytes[J].J Neurooncol,2002,57(1):27-36.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部